Completed OBSERVATIONAL NCT05365542

Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life (ClotSigns)

Mapping of Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life

Sponsor: University Hospital, Ghent

Conditions Blood Coagulation

Interventions Bleeding Questionnaires Hemodialyzer scanning Quality of life questionnaire Visual inspection of the limbs

Updated 5 times since 2022 Last updated: May 3, 2023 Started: Apr 27, 2022 Primary completion: Jul 10, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Blood Coagulation and is currently completed. University Hospital, Ghent leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jun 2022 — Jun 2023 [monthly]

Recruiting

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Ghent

Data source: University Hospital, Ghent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ghent, Belgium